• Target：
• Collagen I

• Fields：
• >>PI3K-Akt signaling pathway;>>Focal adhesion;>>ECM-receptor interaction;>>Platelet activation;>>Relaxin signaling pathway;>>AGE-RAGE signaling pathway in diabetic complications;>>Protein digestion and absorption;>>Amoebiasis;>>Human papillomavirus infection;>>Proteoglycans in cancer;>>Diabetic cardiomyopathy

• Gene Name：
• COL1A2

• Protein Name：
• Collagen alpha-2(I) chain (Alpha-2 type I collagen)

• Human Gene Id：
• 1278

• Human Swiss Prot No：
• P08123

• Mouse Gene Id：
• 12843

• Mouse Swiss Prot No：
• Q01149

• Rat Gene Id：
• 84352

• Rat Swiss Prot No：
• P02466

• Immunogen：
• Synthesized peptide derived from human Collagen I Polyclonal

• Specificity：
• This antibody detects endogenous levels of Collagen I.

• Formulation：
• Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

• Source：
• Polyclonal, Rabbit,IgG

• Dilution：
• WB 1:500-2000, ELISA 1:10000-20000

• Purification：
• The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

• Concentration：
• 1 mg/ml

• Storage Stability：
• -15°C to -25°C/1 year(Do not lower than -25°C)

• Other Name：
• Collagen alpha-2(I) chain (Alpha-2 type I collagen)

• Observed Band(KD)：
• 115kD

• Background：
• This gene encodes the pro-alpha2 chain of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIB, recessive Ehlers-Danlos syndrome Classical type, idiopathic osteoporosis, and atypical Marfan syndrome. Symptoms associated with mutations in this gene, however, tend to be less severe than mutations in the gene for the alpha1 chain of type I collagen (COL1A1) reflecting the different role of alpha2 chains in matrix integrity. Three transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008],

• Function：
• disease:A chromosomal rearrangement involving COL1A2 may be a cause of lipoblastomas, which are benign tumors resulting from transformation of adipocytes, usually diagnosed in children. Translocation t(7;8)(p22;q13) with PLAG1.,disease:Defects in COL1A2 are a cause of osteogenesis imperfecta type I (OI-I) [MIM:166200]. OI-I is a dominantly inherited serious newborn disease characterized by bone fragility, normal stature, little or no deformity, blue sclerae and hearing loss in 50% of families. Dentinogenesis imperfecta is rare and may distinguish a subset of OI type I (formation of dentine).,disease:Defects in COL1A2 are a cause of osteogenesis imperfecta type II (OI-II) [MIM:166210]; also known as osteogenesis imperfecta congenita (OIC) or lethal perinatal. OI-II is a serious newborn disease that diffusely affects bone. Infants are born with multiple fractures, which lead to shortening

• Subcellular Location：
• Secreted, extracellular space, extracellular matrix .

• Expression：
• Forms the fibrils of tendon, ligaments and bones. In bones the fibrils are mineralized with calcium hydroxyapatite.

rhPDGF-BB combined with ADSCs in the treatment of Achilles tendinitis via miR-363/PI3 K/Akt pathway. MOLECULAR AND CELLULAR BIOCHEMISTRY 2017 Aug 01 WB Human,Rat 1:1000 tendons tissue hADSCs

Inhibition of microRNA‑155 ameliorates cardiac fibrosis in the process of angiotensin II‑induced cardiac remodeling. Molecular Medicine Reports Mol Med Rep. 2017 Nov;16(5):7287-7296 WB Mouse 1:1000 heart tissue cardiac fibroblasts

Anti–Na+/K+-ATPase DR antibody attenuates UUO-induced renal fibrosis through inhibition of Na+/K+-ATPase α1–dependent HMGB1 release INTERNATIONAL IMMUNOPHARMACOLOGY Wu-jun Xue IHC Mouse kidney tissues

Urea Transporter Inhibitor 25a Reduces Ascites in Cirrhotic Rats Biomedicines Baoxue Yang WB Rat liver

sST2: A Bridge Between Sirt1/p53/p21 Signal-Induced Senescence and TGF-β1/Smad2/3 Regulation of Cardiac Fibrosis in Mouse Viral Myocarditis INFLAMMATION Lu Hongxiang WB Mouse mouse cardiac fibroblasts (MCFs)

20(S)-ginsenoside Rg3 exerts anti-fibrotic effect after myocardial infarction by alleviation of fibroblasts proliferation and collagen deposition through TGFBR1 signaling pathways. Yingchun Zhou WB Mouse，Rat myocardial cardiac fibroblasts (CFs)

Tangeretin attenuates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via the PI3K/Akt pathway. Frontiers in Pharmacology Pengfei Yi WB Human，Mouse lung tissue A549 cell

CXCL4:NLRP3-mediated pyroptosis product that regulates cardiac fibrosis INTERNATIONAL IMMUNOPHARMACOLOGY Jing Wei WB Mouse 1:1000 heart tissue Mouse myocardial fibroblasts (MCF)

Urea transporter UT-A1 as a novel drug target for hyponatremia FASEB JOURNAL Nannan Li WB Rat kidney tissue

• June 19-2018
• WESTERN IMMUNOBLOTTING PROTOCOL

• June 19-2018
• IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL

• June 19-2018
• IMMUNOFLUORESCENCE PROTOCOL

• September 08-2020
• FLOW-CYTOMEYRT-PROTOCOL

• May 20-2022
• Cell-Based ELISA│解您多样本WB检测之困扰

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN

• July 13-2018
• CELL-BASED-COLORIMETRIC-ELISA-PROTOCOL-FOR-TOTAL-PROTEIN

• July 13-2018
• Antibody-FAQs